and legal reforms: Gateway to innovation and global integration -- Chapter 3: The golden age of the Chinese biopharma …: Explosive growth in a thriving ecosystem -- Chapter 4: Innovation in the Chinese biopharma: From me-too to First … country with no innovation in drug discovery, to a country which starts to out-license its biopharma technology to the rest of …

"This book reports empirical material from three case studies in the pharmaceutical industry, the biotechnology …

innovation. This sentiment stems, in large part, from the belief that pharmaceutical research and development (R&D) entails … significant costs and resources. I argue that if the role of the patent regime is one of fostering higher amounts of investment in … whether or not the underlying idea behind the drug is “new” and “inventive,” two central tenets of patent law. Rather, any …

intellectual property right design. We derive conclusions in the simplest, one-time innovation, case then investigate how these … optimal procurement of innovation are considered. Finally, we sketch enforcement and competition policy issues. …